Assessment of a Novel Vaccine Against Rabbit Hemorrhagic Disease Virus in Young Rabbits

Viral Immunol. 2016 Dec;29(10):583-585. doi: 10.1089/vim.2016.0093. Epub 2016 Nov 11.

Abstract

Rabbit hemorrhagic disease virus (RHDVb) is the new variant of the classical RHDV, a virulent pathogen responsible for an acute disease in young rabbits. The virus invades internal organs, especially the liver, spleen, kidneys, and gut; prevents coagulation; and causes liver necrosis. This eventually leads to quick death of the animal because of hemorrhage. In this study, we evaluated the effects of a new vaccine against RHDVb in rabbits at a young age, after experimental infection using four different viral isolates. Our findings show that the vaccine had a protective effect with survival rates reaching 80-100% against the different isolates. These results suggest that this vaccine, when applied to young animals, is an effective tool to protect against the disease caused by RHDVb in rabbitries.

Keywords: RHDVb; disease; immunization; rabbits; vaccination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Caliciviridae Infections / mortality
  • Caliciviridae Infections / prevention & control*
  • Caliciviridae Infections / veterinary*
  • Hemorrhagic Disease Virus, Rabbit / immunology*
  • Rabbits
  • Survival Rate
  • Vaccines, Inactivated / administration & dosage
  • Vaccines, Inactivated / immunology
  • Viral Vaccines / administration & dosage
  • Viral Vaccines / immunology*

Substances

  • Vaccines, Inactivated
  • Viral Vaccines